NHS priorities

Whether it’s to prepare for the next Pharmacy Quality Scheme deadline, or to increase your confidence in helping people with a learning disability, this section provides topic-specific pages that link to current NHS priorities. This section will support you in keeping your knowledge and skills up to date in order to provide high-quality pharmacy services and be service-ready.

Clinical pharmacy

Our clinical portfolio is expanding on a frequent basis, helping you to advance your knowledge and skills and deliver medicines optimisation in practice for all sectors of pharmacy. From two new focal points a year to our small group learning for hospital pharmacists – Optimise – this section focuses on clinical pharmacy, diseases and therapeutics.

Public health

The public health agenda is embedded in pharmacy, yet topics such as emergency contraception or stop smoking support are as prevalent as ever. As well as our public health workshops, use this section to access a wide range of resources to assure and maintain your competence, all underpinned by the Declaration of Competence system.

CPPE Optimise programmes

Asthma biologics: Focus on eligibility and monitoring

Aim

The purpose of this programme is to increase your knowledge, skills and confidence of the use of asthma biologics in the management of severe asthma. The programme supports pharmacy professionals to improve outcomes for people with respiratory disease as part of the NHS Long Term Plan.

Background learning

The Asthma biologics: focus on eligibility and monitoring Optimise programme assumes you have some prior knowledge of the topic area. If you wish to revise your knowledge, you may find our Fundamentals of respiratory therapeutics e-course helpful as an optional learning resource.

Small group learning

This workshop involves 20 minutes of preparation for each participant and a 40-minute group session. During the small group learning session, activities will allow learners to test their knowledge, debate controversial topics, make justified clinical decisions and practice communicating with patients and/or other healthcare professionals.

Learner resources

You must be logged in to download these resources.

Facilitator's resources

You must be logged in to download these resources.

Next steps

After the workshop, consider your next steps:

Further reading

Consider any other learning resources which may support your next steps, including:

View acknowledgments, references and brand names

Expert and programme contributor
Lynn Elsey, Consultant Respiratory Pharmacist, Manchester University NHS Foundation Trust

CPPE programme developer
Hollie Mount, learning development pharmacist

Content contributors
Clara Alonso Malpartida, CPPE education supervisor and primary care pharmacist
Gráinne d’Ancona, consultant pharmacist for respiratory medicine, Guy’s and St Thomas’ NHS Foundation Trust and senior lecturer at King’s College London
Cate Dawes, CPPE senior pharmacist and module lead primary care pathways
Minna Korjonen, person with lived experience
Rachel Murray, senior learning development pharmacist
Ravijyot Saggu, Respiratory Pharmacist & Chair – UKCPA Respiratory Committee
Angus Stewart, CPPE editor
Trudi Ward, CPPE education supervisor

Reviewers
Hannah Joplin, Severe Asthma and Lead Respiratory Pharmacist, Liverpool University Hospitals NHS Foundation Trust Ravijyot Saggu, Respiratory Pharmacist & Chair – UKCPA Respiratory Committee

CPPE reviewers
Hayley Berry, lead learning development pharmacist
Rachel Murray, senior learning development pharmacist

Piloted by
Manchester University NHS Foundation Trust
Bassett Road Surgery, Leighton Buzzard, Bedfordshire

CPPE editor
Risha Alimchandani, assistant editor

Disclaimer
We have developed this learning programme to support your practice in this topic area. We recommend that you use it in combination with other established reference sources. If you are using it significantly after the date of initial publication, then you should refer to current published evidence. CPPE does not accept responsibility for any errors or omissions.

External websites
CPPE is not responsible for the content of any non-CPPE websites mentioned in this programme or for the accuracy of any information to be found there.

All web links were accessed in December 2024.

Brand names and acknowledgments
CPPE acknowledges the following brand names and registered trademarks mentioned throughout this programme: Fostair 200/6 NEXThaler®, Easyhaler Salbutamol 100 microgram®

References

  1. Global Initiative for Asthma. Difficult-to-treat & Severe Asthma in adolescent and adult patients: Diagnosis and Management. April 2019. org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf
  2. Asthma + Lung UK. What is severe asthma? 30 November 2022. org.uk/conditions/severe-asthma/what-severe-asthma
  3. Health Innovation Oxford & Thames Valley. Asthma biologics toolkit. 11 April 2023. org/our-work/respiratory/asthma-biologics-toolkit/asthma-biologics-overview/
  4. Oxford Academic Health Science Network. ACC Consensus Pathway: Management of Uncontrolled Asthma in Adults. June 2022. org/wp-content/uploads/2022/06/AAC-Pathway-16.9_FINAL-No-NHS.pdf